A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer
Abstract Background Tumor-derived autophagosome vaccines (DRibbles) have the potential to broaden immune response to poorly immunogenic tumors. Methods Autologous vaccine generated from tumor cells harvested from pleural effusions was administered to patients with advanced NSCLC with the objectives...
Main Authors: | Rachel E. Sanborn, Helen J. Ross, Sandra Aung, Anupama Acheson, Tarsem Moudgil, Sachin Puri, Traci Hilton, Brenda Fisher, Todd Coffey, Christopher Paustian, Michael Neuberger, Edwin Walker, Hong-Ming Hu, Walter J. Urba, Bernard A. Fox |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2017-12-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-017-0306-6 |
Similar Items
-
Discrimination of Exudative Pleural Effusions Based on Pleural Adenosine Deaminase (ADA)-C-Reactive Protein (CRP) Levels, and Their Combination: An Observational Prospective Study
by: Garifallia Perlepe, et al.
Published: (2021-08-01) -
Diagnostic value of calprotectin in differentiation between benign and malignant pleural effusion
by: Omar M. Mohammed, et al.
Published: (2019-07-01) -
Yield of medical thoracoscopy in undiagnosed exudative pleural effusion: a 3-year retrospective multicenter study
by: Eman Sobh, et al.
Published: (2020-01-01) -
Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study
by: Shinnosuke Takemoto, et al.
Published: (2020-02-01) -
Retrospective study of pleural parasitic infestations: a practical diagnostic approach
by: Jinlin Wang, et al.
Published: (2019-07-01)